solidphas
radioimmunoassay
describ
detect
antibodi
mous
hepat
viru
virus
purifi
veloc
isopycn
gradient
centrifug
plastic
plate
coat
viral
antigen
allow
detect
serotyp
low
titer
antisera
pool
antigen
sever
viral
serotyp
employ
second
antibodi
affinitypurifi
goat
antimous
immunoglobulin
coronavirus
group
envelop
rna
virus
caus
broad
spectrum
diseas
natur
host
tyrel
diseas
includ
enceph
hepat
interstiti
pneumon
nephriti
enter
piazza
spectrum
sever
diseas
produc
coronavirus
vari
age
genet
background
host
rout
infect
size
viru
inoculum
resist
sever
acut
infect
appear
depend
least
part
potenti
replic
mous
hepat
viru
mhv
cell
reticuloendotheli
system
genet
restrict
event
virelizi
allison
weiser
bang
recent
interest
mhv
model
human
hepat
reviv
result
observ
implic
variabl
level
host
import
pathogenesi
diseas
krzystyniak
dupuy
levi
et
al
major
problem
mhv
research
difficulti
obtain
experiment
anim
previous
expos
viru
indic
presenc
antibodi
previous
three
method
util
determin
antibodi
mhv
plaqu
neutral
assay
immunofluoresc
complement
fixat
neutral
immunofluoresc
although
highli
sensit
time
consum
complement
fixat
insensit
use
recent
enzymelink
immunosorb
assay
elisa
kraaijeveld
et
al
describ
becom
commerci
avail
expens
screen
larg
number
mice
use
research
laboratori
work
mhv
therefor
develop
highli
sensit
reproduc
radioimmunoassay
use
screen
larg
number
mice
studi
molecular
biolog
immunopatholog
mhv
origin
growth
murin
cell
line
cll
dbt
cell
describ
previous
levi
et
al
cell
routin
propag
dulbecco
modifi
eagl
medium
dmem
flow
laboratori
inc
rockvil
md
supplement
newborn
calf
serum
biocel
laboratori
carson
citi
ca
ugml
chlortetracyclin
hydrochlorid
grade
ii
sigma
chemic
co
st
loui
mo
buffer
acid
hepe
acid
mop
ntri
hydroxymethyl
sulfon
acid
te
mm
glutamin
sigma
chemic
co
origin
growth
jhm
strain
mhv
previous
describ
mhv
obtain
american
type
cultur
collect
rockvil
md
virus
plaqu
purifi
twice
monolay
dbt
cell
seed
stock
prepar
work
stock
grown
cell
infect
multipl
infect
moi
plaqu
form
unit
pfu
cell
virus
assay
monolay
cell
standard
plaqu
assay
describ
previous
levi
et
al
mhv
grown
high
titer
monolay
cell
virus
harvest
cycl
freez
thaw
clarifi
centrifug
x
g
prepar
aliquot
orthophosph
label
viru
ad
follow
viru
purif
supernat
recov
viru
precipit
ad
ml
ml
nacl
ml
wv
polyethylen
glycol
peg
mopssalin
disodium
ethylen
diamin
tetracet
edta
ph
mm
mop
mm
edta
mm
nacl
baker
scientif
co
philipsburg
nj
wege
et
al
solut
stir
ice
min
viru
pellet
centrifug
x
g
min
pellet
resuspend
small
volum
mopssalineedta
overlay
onto
ml
ww
ktartrat
gradient
centrifug
rpm
sw
rotor
min
gradient
fraction
aliquot
count
liquid
scintil
counter
fraction
contain
viru
pool
dilut
volum
ml
mopssalineedta
overlay
onto
ml
ww
ktartrat
gradient
centrifug
h
rpm
rotor
gradient
fraction
viru
peak
locat
pool
viru
dilut
ml
mopssalineedta
pellet
rpm
min
rotor
viral
pellet
resuspend
ml
carbon
buffer
burst
sonic
viral
protein
concentr
determin
modifi
lowri
assay
describ
previous
levi
et
al
viru
assay
monolay
cell
standard
plaqu
assay
describ
previous
levi
et
al
neutral
sera
heat
inactiv
min
incub
pfu
mhv
min
twohundr
ul
mixtur
layer
onto
confluent
monolay
cell
plastic
cluster
dish
linbro
plastic
mclean
va
min
overlay
agaros
dmem
supplement
fetal
calf
serum
fc
plate
incub
h
incub
stain
gm
crystal
violet
ethanol
enumer
plaqu
flexibl
microtit
plate
dynatech
laboratori
inc
alexandria
va
coat
either
mhv
strain
mixtur
mhv
viru
purifi
gradient
centrifug
individu
well
coat
antigen
dilut
ul
carbon
buffer
ph
incub
overnight
humid
chamber
antigen
crosslink
use
ul
mgml
solut
carbodiimid
hcl
calbiochembehr
corp
la
jolla
ca
follow
morn
plate
wash
repeatedli
ul
aliquot
bovin
serum
albumin
bsa
tween
sodium
azid
phosphat
buffer
salin
pb
ph
spria
buffer
carbodiimid
inactiv
h
plate
repeatedli
wash
spria
buffer
affin
purifi
goat
antimous
immunoglobulin
gamg
specif
activ
x
cpmmg
ad
plate
incub
h
plate
wash
count
gamma
counter
appropri
posit
neg
sera
includ
assay
control
sampl
assay
triplic
virus
grown
cell
describ
grew
tenfold
higher
titer
mhvjhm
mhv
viru
follow
purif
presenc
small
amount
viru
howev
step
distinct
opalesc
band
could
seen
correspond
viru
combin
veloc
isopycn
sediment
ktartrat
densiti
gradient
purifi
viru
appar
homogen
fig
uciml
methioninefre
medium
viru
purifi
cultur
fluid
describ
materi
method
purifi
viru
reduc
electrophores
polyacrylamid
gel
buorograph
prepar
describ
previous
maizel
reduc
form
glycoprotein
dalton
nucleocapsid
protein
n
dalton
el
glycoprotein
dalton
easili
seen
fig
rule
contamin
prepar
methionin
label
viru
electrophores
polyacrylamid
gel
analys
autoradiographi
three
structur
viral
protein
visual
contamin
note
fig
abl
recov
infecti
viru
probabl
repres
minimum
estim
total
recoveri
viral
antigen
base
biolog
activ
certainli
much
could
lost
chemic
physic
treatment
purif
modifi
lowri
techniqu
x
pfu
found
correspond
f
ug
protein
determin
specif
gamg
probe
microtit
plate
coat
ng
mous
igg
ng
igm
lambda
myeloma
ng
igm
kappa
myeloma
ng
iga
myeloma
mopc
kindli
provid
dr
brian
underdown
tabl
twohundr
thousand
cpm
gamg
ad
well
count
antibodi
capabl
detect
igg
effect
also
detect
igm
determin
monoclon
igm
molecul
detect
kappa
greater
lambda
could
consist
antibodi
greater
antikappa
characterist
fact
kappa
myeloma
protein
bind
better
plate
lambda
myeloma
protein
probe
also
detect
iga
antibodi
although
lower
effici
immunoglobulin
class
gamg
probe
shown
react
directli
viral
protein
coat
plate
demonstr
low
background
count
magnitud
antigen
omit
plate
microtit
plate
coat
vari
amount
ng
purifi
test
posit
antibodi
determin
optim
antigen
concentr
antibodi
could
detect
littl
ng
antigen
data
shown
could
easili
detect
ng
fig
optim
sensit
observ
ng
antigen
fig
signific
increas
note
ng
antigen
per
well
fig
therefor
subsequ
determin
antigen
concentr
ngloo
pl
per
well
use
known
posit
neg
sera
titer
antigenco
plate
assay
optim
serum
dilut
dilut
chosen
screen
sera
posit
sera
defin
greater
sd
mean
neg
control
sera
shown
fig
standard
condit
assay
known
posit
sera
could
detect
dilut
ria
compar
plaqu
reduct
assay
commerci
avail
elisa
microbiolog
associ
walkersvil
md
prove
significantli
sensit
either
assay
tabl
sensit
plaqu
reduct
assay
greater
sensit
commerci
avail
elisa
furthermor
follow
seroconvers
infect
aj
mice
abl
detect
antibodi
ria
day
plaqu
neutral
assay
elisa
neg
day
follow
infect
ria
time
sensit
elisa
time
sensit
plaqu
neutral
assay
addit
use
assay
abl
detect
antibodi
varieti
mhv
serotyp
antibodi
could
detect
equal
effici
target
antigen
also
adequ
target
antijhm
sera
howev
sera
low
level
antibodi
mhv
neutral
titer
lio
result
ria
errat
use
either
target
use
pool
purifi
antigen
includ
mhv
abl
detect
sera
neutral
titer
low
eas
hierholz
et
al
demonstr
previous
complementfix
assay
antigen
react
antisera
direct
wide
varieti
strain
mhv
howev
rel
differ
sensit
antisera
mhv
antisera
mhv
least
reactiv
examin
ria
howev
appear
significantli
sensit
problem
case
sera
low
titer
sensit
homolog
plaqu
reduct
assay
mhv
kindli
provid
dr
abigail
smith
yale
univers
occassion
neg
ria
use
target
antigen
howev
abl
detect
antibodi
mhv
major
case
use
pool
antigen
includ
mhv
addit
abl
improv
sensit
assay
strain
ria
describ
paper
proven
fast
highli
sensit
econom
reproduc
assay
suitabl
screen
larg
number
sampl
therefor
use
screen
hybridoma
use
screen
hybridoma
specif
viral
protein
addit
also
employ
assay
detect
outbreak
mhv
breed
coloni
found
satisfactori
one
case
assay
posit
mhv
later
confirm
commerci
avail
elisa
although
plaqu
reduct
assay
neg
second
outbreak
elisa
neg
plaqu
reduct
assay
ria
posit
two
case
assay
neg
mhv
fact
investig
reveal
outbreak
result
ectromelia
sendai
virus
chose
target
antigen
growth
high
titer
tissu
cultur
adequ
antigen
spectrum
cross
react
mhv
serotyp
howev
recommend
use
pool
purifi
antigen
mhv
order
maxim
sensit
assay
strain
mhv
unabl
detect
low
titer
antibodi
mhv
use
target
antigen
well
use
screen
antibodi
mhv
assay
use
quantit
antibodi
method
chosen
determin
antibodi
titer
analog
standard
serolog
endpoint
dilut
assay
complement
fixat
hemagglutin
inhibit
plaqu
neutral
shape
curv
fig
necessari
endpoint
dilut
assay
sinc
linear
portion
curv
increas
sensit
ria
compar
elisa
probabl
due
use
purifi
viral
antigen
affinitypurifi
goat
antimous
probe
high
specif
activ
probe
could
detect
igg
high
sensit
seen
tabl
addit
antip
activ
detect
seen
reactiv
two
monoclon
igm
molecul
appear
antibodi
higher
antikappa
antilambda
activ
possibl
explain
result
increas
bind
kappa
myeloma
plate
iga
also
detect
less
effici
igg
igm
fact
probe
specif
might
explain
abil
detect
earli
seroconvers
mhv
contain
three
structur
protein
nucleocapsid
protein
peplom
glycoprotein
glycoprotein
analog
matrix
protein
neg
strand
virus
el
sturman
sturman
holm
hierholz
et
al
sturman
treat
virion
effect
nondeterg
treat
viru
target
antigen
data
shown
suggest
tween
buffer
make
viral
envelop
permeabl
thu
allow
intern
antigen
accesss
antibodi
although
major
compon
mhv
nucleocapsid
protein
fig
dilut
chosen
screen
system
unsatur
therefor
probabl
detect
antibodi
three
protein
proport
present
investig
way
rigor
establish
whether
fact
true
